tibalosin has been researched along with atenolol in 1 studies
*Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect. [MeSH]
*Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amery, A; Fagard, R; Fiocchi, R; Lijnen, P; M'Buyamba-Kabangu, JR; Staessen, J | 1 |
1 trial(s) available for tibalosin and atenolol
| Article | Year |
|---|---|
Chronic treatment with tibalosine in essential hypertension.
Topics: Adult; Antihypertensive Agents; Atenolol; Blood Pressure; Chlorthalidone; Clinical Trials as Topic; Double-Blind Method; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Potassium; Propanolamines; Random Allocation | 1986 |